Medicine & Life Sciences
Pulmonary Hypertension
100%
Pulmonary Arterial Hypertension
93%
Familial Primary Pulmonary Hypertension
76%
alpha 1-Antitrypsin Deficiency
73%
Endarterectomy
61%
Lung
61%
Chronic Obstructive Pulmonary Disease
44%
Pulmonary Embolism
40%
Multicenter Studies
29%
Venous Thromboembolism
28%
Traffic-Related Pollution
26%
Eukaryotic Initiation Factor-2
25%
Cardiovascular Diseases
24%
Angiopoietin-2
23%
Eukaryotic Initiation Factors
22%
Biomarkers
21%
Hemodynamics
20%
Pancreatic Elastase
19%
Air Pollution
19%
Validation Studies
18%
Patient Reported Outcome Measures
18%
Genome-Wide Association Study
17%
Coronavirus
16%
Anticoagulants
15%
C-Reactive Protein
14%
Mortality
14%
Mutation
14%
Type II Bone Morphogenetic Protein Receptors
14%
HLA-DPA1 antigen
13%
Observational Studies
13%
Survival
13%
Phosphotransferases
12%
Lung Diseases
12%
Meta-Analysis
12%
HLA-DPB1 antigen
12%
Particulate Matter
12%
Vitamin K
12%
Cohort Studies
11%
Genes
10%
Pulmonary Veno-Occlusive Disease
9%
Computed Tomography Angiography
9%
Hemorrhage
9%
Transplants
8%
Epidemiologic Confounding Factors
7%
Genotype
7%
Vascular Resistance
7%
Embolism
6%
Buffers
6%
Thrombosis
6%
Heart Failure
6%